dacarbazine has been researched along with Liver Dysfunction in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (50.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Finnes, H; Kenderian, SS; Rana, V; Sonbol, MB; Witzig, TE | 1 |
Alarcón, C; Alonso, JM; Chamorro, C; deAndrés-Galiana, EJ; Del Coz, JJ; Fernández, R; Fernández-Martínez, JL; Gonzalez, S; González-Ordóñez, A; González-Rodríguez, AP; Luaces, O; Medina, J; Morán, M; Nogués, EA; Ortiz, S; Palicio, MA; Payer, AR; Solano, J; Taboada, F; Vargas, M; Vicente, JM; Zanabilli, Y | 1 |
Dixit, S; Hingorani, M; Rajaraman, C; Rowland-Hill, C; Salvage, D | 1 |
Doepfmer, K; Féaux de Lacroix, W; Groth, W; Hauk, H; Runne, U; Wacker, D | 1 |
Classen, M; Dancygier, H; Leuschner, U; Milbradt, R; Runne, U | 1 |
Braun, S; Heine, M; Paschke, R; Usadel, KH | 1 |
Czarnetzki, BM; Frosch, PJ; Gottschalk, I; Grundmann, E; Macher, E | 1 |
Lusch, CJ; Mastrangelo, MJ; McClay, E | 1 |
8 other study(ies) available for dacarbazine and Liver Dysfunction
Article | Year |
---|---|
Therapeutic options for patients with lymphoma and liver dysfunction or failure during mechlorethamine shortage.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Liver Diseases; Lymphoma; Male; Mechlorethamine; Middle Aged; Positron-Emission Tomography; Prednisone; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine | 2014 |
On the prediction of Hodgkin lymphoma treatment response.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Incidence; Inflammation; Iron Overload; Liver Diseases; Machine Learning; Male; Middle Aged; Neoplasm Staging; Prognosis; Remission Induction; Retrospective Studies; Vinblastine | 2015 |
Hypernatremia-associated myelinolysis following the management of sepsis in a patient with glioblastoma treated with radiotherapy and temozolomide.
Topics: Antineoplastic Agents; Brain Diseases; Brain Neoplasms; Carcinoma; Carcinoma, Papillary; Dacarbazine; Diabetes Mellitus; Fatal Outcome; Glioblastoma; Humans; Hypernatremia; Hypertension; Liver Diseases; Male; Middle Aged; Neoplasms, Second Primary; Radiotherapy, Conformal; Sepsis; Temozolomide; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2013 |
Acute liver dystrophy with thrombosis of hepatic veins: a fatal complication of dacarbazine treatment.
Topics: Chemical and Drug Induced Liver Injury; Dacarbazine; Female; Hepatic Veins; Humans; Liver Diseases; Male; Melanoma; Middle Aged; Necrosis; Skin Neoplasms; Thrombosis | 1983 |
Dacarbazine (DTIC)-induced human liver damage light and electron-microscopic findings.
Topics: Chemical and Drug Induced Liver Injury; Dacarbazine; Humans; Liver; Liver Diseases; Male; Middle Aged | 1983 |
Mechanisms of hepatotoxicity caused by dacarbazine in rats.
Topics: Alanine Transaminase; Animals; Blood Platelets; Chemical and Drug Induced Liver Injury; Cholinesterases; Dacarbazine; Enzyme Induction; Leukocytes; Liver; Liver Diseases; Microsomes, Liver; Rats; Rats, Sprague-Dawley | 1993 |
Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanoma.
Topics: Budd-Chiari Syndrome; Chemical and Drug Induced Liver Injury; Dacarbazine; Drug Hypersensitivity; Eosinophils; Female; Humans; Liver Diseases; Melanoma; Middle Aged; Skin Neoplasms | 1979 |
Allergy-induced hepatic toxicity associated with dacarbazine.
Topics: Autopsy; Budd-Chiari Syndrome; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Dacarbazine; Drug Hypersensitivity; Humans; Laparotomy; Liver Diseases; Male; Melanoma; Middle Aged; Skin Diseases | 1987 |